Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy 2023-10-13 03:00
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival 2023-10-12 20:50
Akeso Announced The Lancet Oncology Publishes Promising Clinical Results from Cadonilimab in Patients with Advanced Solid Tumours (COMPASSION-03/AK104-201) 2023-10-12 20:00
Phabuilder Presents "Phamily" at the Go!PHA Congress: A New Era for PHA Materials 2023-10-12 20:00
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1 Clinical Study of HL192 2023-10-12 19:00
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate 2023-10-12 19:00
Asieris Unveiled Results of Its Phase III Clinical Study for APL-1706, an Imaging Drug for Diagnosis or Surgery of Bladder Cancer, at the SIU 2023 Congress 2023-10-12 18:49
So-Young Announces Board Change 2023-10-12 18:00
MicuRx announces poster presentation and participation in ID Week 2023 Conference 2023-10-11 23:33
SINGAPORE AND JAPAN CLINICIAN-SCIENTISTS COLLABORATE ON GROUNDBREAKING TELESURGERY TRIAL SPANNING OVER 5,000KM 2023-10-11 22:13
Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China 2023-10-11 17:20
TaiGen Enters Exclusive License Agreement with YSP 2023-10-11 11:24
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023 2023-10-11 08:49
Lunit to Showcase 9 AI-based Research Results at ESMO 2023 2023-10-10 21:00
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503 2023-10-10 20:00
GenFleet Starts Phase Ib/II Trial of GFH009 (Highly Selective CDK9 Inhibitor) Treating Patients with Relapsed/Refractory Peripheral T-cell Lymphomas (PTCL) 2023-10-10 19:00
GC Biopharma Signs Power Purchase Agreement with SK E&S 2023-10-10 14:20
CanariaBio and Hikma announce the signing of distribution and license agreement for oregovomab in MENA Region 2023-10-10 12:00
Dr. Ming H. Wu, Former Senior Vice President of Engineering at Edwards Lifesciences, Joins Medeologix as Board Member and Advisor 2023-10-09 23:00
TransThera announces two oral presentations of tinengotinib clinical data at 2023 ESMO and SABCS annual meetings 2023-10-09 21:00
1 71 72 73 74 75 800